This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Prolyl hydroxylase domain
From Proteopedia
(Difference between revisions)
| Line 20: | Line 20: | ||
**[[6st3]] - hPHD2 catalytic domain + Mn + pyrimidin derivative<br /> | **[[6st3]] - hPHD2 catalytic domain + Mn + pyrimidin derivative<br /> | ||
**[[6yvt]] - hPHD2 catalytic domain + Mn + pyridin derivative<br /> | **[[6yvt]] - hPHD2 catalytic domain + Mn + pyridin derivative<br /> | ||
| - | **[[6qgv]], [[5a3u]] - hPHD2 catalytic domain + Mn + inhibitor<br /> | + | **[[6qgv]], [[5a3u]], [[6st3]], [[6yvt]], [[6zbn]], [[6zbo]] - hPHD2 catalytic domain + Mn + inhibitor<br /> |
**[[5ox6]], [[6ox5]] - hPHD2 catalytic domain + Mn + drug<br /> | **[[5ox6]], [[6ox5]] - hPHD2 catalytic domain + Mn + drug<br /> | ||
**[[5lat]], [[5lb6]], [[5lbb]], [[5lbc]], [[5lbe]], [[5lbf]], [[4uwd]] - hPHD2 catalytic domain (mutant) + Mn + quinolin derivative<br /> | **[[5lat]], [[5lb6]], [[5lbb]], [[5lbc]], [[5lbe]], [[5lbf]], [[4uwd]] - hPHD2 catalytic domain (mutant) + Mn + quinolin derivative<br /> | ||
| - | **[[ | + | **[[6yvx]], [[6yvz]] - hPHD2 catalytic domain + Mn + peptide<br /> |
| + | **[[6yw3]] - hPHD2 catalytic domain + Mn + peptide + oxalylglycine<br /> | ||
| + | **[[6yw1]], [[6yw2]], [[6yw4]] - hPHD2 catalytic domain (mutant) + Mn + peptide + oxalylglycine<br /> | ||
*Prolyl hydroxylase domain containing other metal ions | *Prolyl hydroxylase domain containing other metal ions | ||
| - | **[[2y33]] – hPHD2 catalytic domain residues | + | **[[2y33]] – hPHD2 catalytic domain residues + Zn + quinolin derivative – human<br /> |
| - | **[[3ouh]], [[3oui]], [[5v18]] - hPHD2 catalytic domain + Fe + inhibitor<br /> | + | **[[3ouh]], [[3oui]], [[5v18]], [[6nmq]], [[6yvw]], [[6yw0]] - hPHD2 catalytic domain + Fe + inhibitor<br /> |
**[[4kbz]] - hPHD2 catalytic domain (mutant) + Fe + inhibitor<br /> | **[[4kbz]] - hPHD2 catalytic domain (mutant) + Fe + inhibitor<br /> | ||
**[[4jzr]] - hPHD2 catalytic domain + Ni + inhibitor<br /> | **[[4jzr]] - hPHD2 catalytic domain + Ni + inhibitor<br /> | ||
Revision as of 11:00, 1 February 2022
| |||||||||||
3D Structures of prolyl hydroxylase domain
Updated on 01-February-2022
References
- ↑ Stolze IP, Mole DR, Ratcliffe PJ. Regulation of HIF: prolyl hydroxylases. Novartis Found Symp. 2006;272:15-25; discussion 25-36. PMID:16686427
- ↑ Rosen M D, Venkatesan H, Peltier H M, Bembenek S D, Kanelakis K C, Zhao L X, Leonard B E, Hocutt F M, Wu X, Palomino H L, Brondtetter T I, Haugh P V, Cagnon L, Yan W, Liotta L A, Young A, Mirzadegan T, Shankley N P, Barrett T D, Rabinowitz M H. Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues. ACS Medicinal Chemical Letters. 2010 Oct 5.
Created with the participation of Andrew Winslow.

